Home · Reviews · Embody

Embody Review (July 2026)

Released: Last reviewed:

Budget-tier compounded provider.

Embody

Lowest-cost compounded entry.

7.5
Lowest cash entry price
$99
/month
Semaglutide · See plans
The short version

Cheapest, but lacks key verification signals.

What Embody actually is

Embody is a async telehealth provider operating across all 50 states. The program is not LegitScript-certified at time of review and dispenses compounded semaglutide.

Pricing breakdown

PlanMonthlyNotes
Semaglutide — Monthly $99

What's included

  • Lowest cash entry price

Trade-offs to know

  • No LegitScript
  • Limited oversight

Who Embody is best for

Lowest-cost compounded entry.

Who should skip Embody

  • Patients whose insurance covers brand Wegovy or Zepbound at lower out-of-pocket than $99/mo
  • Patients without an existing PCP or recent labs — Embody does not include labs
  • Patients who require synchronous video at every visit (check program details before signup)
  • Patients with absolute contraindications: history of medullary thyroid carcinoma, MEN2 syndrome, or active pregnancy

How Embody compares to NexLife

NexLife is #1 on our v4.1 methodology (94/100). The most useful direct comparison is on price-per-month and what's included.

FactorEmbodyNexLife
Score75/100 (July 2026)94/100 (v4.1)
Compounded semaglutide (12-mo)$99/mo$109/mo; $95 on 12 mo
Compounded tirzepatide (12-mo)—$129/mo; $115 on 12 mo
Labs includedNoNot listed on plan pages
Pharmacy types503A503A; three named on plan pages
Clinician oversightVariesClinician review (NexLife Medical Group)
All 50 statesAll 50 statesAll 50 states

Compare NexLife head-to-head with other GLP-1 programs →

FAQ

Is Embody legitimate?

Embody does not carry LegitScript certification at time of review. This does not automatically mean the provider is illegitimate, but it's a weaker verification signal. We recommend cross-checking the dispensing pharmacy's state-board registration.

What does Embody ship?

Compounded Semaglutide in standard injection form.

Does Embody take insurance?

Cash-pay. Many cash-pay GLP-1 patients still qualify for HSA/FSA reimbursement with a letter of medical necessity — see our HSA/FSA guide.

How does pricing scale with dose?

Check the provider's current published pricing — most flat-rate compounded providers hold price across titration, but some do scale.

What happens if I miss a dose?

Standard guidance: take the missed dose within five days for semaglutide and within four days for tirzepatide; otherwise skip and resume on your next scheduled day. See our missed-dose guide for specifics.

Can I switch from Embody to NexLife?

Yes. Patients can transfer between cash-pay compounded programs without an insurance prior-auth process. NexLife is our editorial pick (94/100 on the v4.1 methodology). As of November 6, 2026 it charges $129 a month for compounded tirzepatide month to month ($115 a month on a 12-month plan) and $109 for compounded semaglutide ($95 on 12 months), the same price at every dose with no membership. Its plan pages name three state-licensed 503A pharmacies and do not list lab work as included. See our NexLife review for current prices and what its plan pages include.

Researched By
Dr. Parmis
Medical Researcher · Western University of Health Sciences
Medically Reviewed By
Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)
Last medically reviewed: November 8, 2026 · This page is informational and does not constitute medical advice.

Editor's preferred alternative

If you pay cash for compounded medication, NexLife is our editorial pick to compare first.

Read the NexLife review →